198 related articles for article (PubMed ID: 33303821)
21. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo.
Park E; Wong V; Guan X; Oprescu AI; Giacca A
J Endocrinol; 2007 Nov; 195(2):323-31. PubMed ID: 17951543
[TBL] [Abstract][Full Text] [Related]
22. miR-218 regulates diabetic nephropathy via targeting IKK-β and modulating NK-κB-mediated inflammation.
Li M; Guo Q; Cai H; Wang H; Ma Z; Zhang X
J Cell Physiol; 2020 Apr; 235(4):3362-3371. PubMed ID: 31549412
[TBL] [Abstract][Full Text] [Related]
23. IRS1Ser³⁰⁷ phosphorylation does not mediate mTORC1-induced insulin resistance.
Herrema H; Lee J; Zhou Y; Copps KD; White MF; Ozcan U
Biochem Biophys Res Commun; 2014 Jan; 443(2):689-93. PubMed ID: 24333417
[TBL] [Abstract][Full Text] [Related]
24. Tangshenning Attenuates High Glucose-Induced Podocyte Injury via Restoring Autophagy Activity through Inhibiting mTORC1 Activation.
Xu J; Shan X; Chen C; Gao Y; Zou D; Wang X; Wang T; Shi Y
J Diabetes Res; 2022; 2022():1610416. PubMed ID: 35799948
[TBL] [Abstract][Full Text] [Related]
25. Sustained Action of Ceramide on the Insulin Signaling Pathway in Muscle Cells: IMPLICATION OF THE DOUBLE-STRANDED RNA-ACTIVATED PROTEIN KINASE.
Hage Hassan R; Pacheco de Sousa AC; Mahfouz R; Hainault I; Blachnio-Zabielska A; Bourron O; Koskas F; Górski J; Ferré P; Foufelle F; Hajduch E
J Biol Chem; 2016 Feb; 291(6):3019-29. PubMed ID: 26698173
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
[TBL] [Abstract][Full Text] [Related]
27. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
[TBL] [Abstract][Full Text] [Related]
28. Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy.
Denhez B; Rousseau M; Dancosst DA; Lizotte F; Guay A; Auger-Messier M; Côté AM; Geraldes P
Diabetes; 2019 May; 68(5):1026-1039. PubMed ID: 30862678
[TBL] [Abstract][Full Text] [Related]
29. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
[TBL] [Abstract][Full Text] [Related]
30. Linagliptin affects IRS1/Akt signaling and prevents high glucose-induced apoptosis in podocytes.
Mima A; Yasuzawa T; Nakamura T; Ueshima S
Sci Rep; 2020 Apr; 10(1):5775. PubMed ID: 32238837
[TBL] [Abstract][Full Text] [Related]
31. IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes.
Santamaria B; Marquez E; Lay A; Carew RM; González-Rodríguez Á; Welsh GI; Ni L; Hale LJ; Ortiz A; Saleem MA; Brazil DP; Coward RJ; Valverde ÁM
Biochim Biophys Acta; 2015 Dec; 1853(12):3224-34. PubMed ID: 26384875
[TBL] [Abstract][Full Text] [Related]
32. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
[TBL] [Abstract][Full Text] [Related]
33. Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.
Han MS; Lim YM; Quan W; Kim JR; Chung KW; Kang M; Kim S; Park SY; Han JS; Park SY; Cheon HG; Dal Rhee S; Park TS; Lee MS
J Lipid Res; 2011 Jun; 52(6):1234-1246. PubMed ID: 21447485
[TBL] [Abstract][Full Text] [Related]
34. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
[TBL] [Abstract][Full Text] [Related]
35. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
[TBL] [Abstract][Full Text] [Related]
36. Amino Acids Attenuate Insulin Action on Gluconeogenesis and Promote Fatty Acid Biosynthesis via mTORC1 Signaling Pathway in trout Hepatocytes.
Dai W; Panserat S; Plagnes-Juan E; Seiliez I; Skiba-Cassy S
Cell Physiol Biochem; 2015; 36(3):1084-100. PubMed ID: 26112996
[TBL] [Abstract][Full Text] [Related]
37. IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance.
Lee DF; Kuo HP; Chen CT; Wei Y; Chou CK; Hung JY; Yen CJ; Hung MC
Int J Mol Med; 2008 Nov; 22(5):633-8. PubMed ID: 18949383
[TBL] [Abstract][Full Text] [Related]
38. Lipotoxicity dysregulates the immunoproteasome in podocytes and kidneys in type 2 diabetes.
Lee HS; Suh JY; Kang BC; Lee E
Am J Physiol Renal Physiol; 2021 Apr; 320(4):F548-F558. PubMed ID: 33586497
[TBL] [Abstract][Full Text] [Related]
39. Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death.
Tejada T; Catanuto P; Ijaz A; Santos JV; Xia X; Sanchez P; Sanabria N; Lenz O; Elliot SJ; Fornoni A
Kidney Int; 2008 Jun; 73(12):1385-93. PubMed ID: 18385666
[TBL] [Abstract][Full Text] [Related]
40. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.
Jiang G; Dallas-Yang Q; Biswas S; Li Z; Zhang BB
Biochem J; 2004 Jan; 377(Pt 2):339-46. PubMed ID: 14556646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]